Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Additional filters

Article Language

Species

Sex

Age

Other

Search Results

6,021 results

Filters applied: . Clear all
Results are displayed in a computed author sort order. The Publication Date timeline is not available.
Page 1
Efficacy and safety of olaparib, olaparib plus bevacizumab and niraparib maintenance treatment in Japanese patients with platinum-sensitive advanced ovarian cancer.
Nakamura K, Matsuoka H, Yorimitsu M, Ogawa M, Kanemori M, Sueoka K, Kozai A, Nakamura H, Haruma T, Shiroyama Y, Hayata Y, Sugii H, Ueda A, Kurihara S, Urayama S, Shimizu M, Masuyama H. Nakamura K, et al. Among authors: shimizu m. Jpn J Clin Oncol. 2024 Jan 7;54(1):31-37. doi: 10.1093/jjco/hyad125. Jpn J Clin Oncol. 2024. PMID: 37721176 Free PMC article.
Relationship Between Hematological Toxicities During Maintenance Treatment and During Chemotherapy Before Maintenance Treatment in Patients With Platinum-sensitive Relapsed Ovarian Cancer.
Matsuoka H, Nakamura K, Yorimitsu M, Ogawa M, Kanemori M, Sueoka K, Kozai A, Nakamura H, Haruma T, Shiroyama Y, Hayata Y, Sugii H, Ueda A, Kurihara S, Urayama S, Shimizu M, Masuyama H. Matsuoka H, et al. Among authors: shimizu m. Anticancer Res. 2023 Aug;43(8):3653-3658. doi: 10.21873/anticanres.16546. Anticancer Res. 2023. PMID: 37500145
Lymphadenectomy and chemotherapy are effective treatments for patients with 2023 international federation of gynecology and obstetrics stage IIC-high risk endometrial cancer in Japan.
Tani Y, Nakamura K, Yorimitsu M, Seki N, Nakanishi M, Itou H, Shimizu M, Yamamoto D, Takahara E, Masuyama H. Tani Y, et al. Among authors: shimizu m. Int J Clin Oncol. 2024 Nov 9. doi: 10.1007/s10147-024-02647-4. Online ahead of print. Int J Clin Oncol. 2024. PMID: 39516301
Guselkumab in patients with moderately to severely active ulcerative colitis (QUASAR): phase 3 double-blind, randomised, placebo-controlled induction and maintenance studies.
Rubin DT, Allegretti JR, Panés J, Shipitofsky N, Yarandi SS, Huang KG, Germinaro M, Wilson R, Zhang H, Johanns J, Feagan BG, Hisamatsu T, Lichtenstein GR, Bressler B, Peyrin-Biroulet L, Sands BE, Dignass A; QUASAR Study Group. Rubin DT, et al. Lancet. 2024 Dec 17:S0140-6736(24)01927-5. doi: 10.1016/S0140-6736(24)01927-5. Online ahead of print. Lancet. 2024. PMID: 39706209
Age-specific issues of accidental exposure in pediatric food allergy: A multicenter survey.
Itazawa T, Oguri M, Kato T, Shimizu M, Nakabayashi M, Wada T, Ito Y, Higuchi O, Yamamoto J, Kawashiri M, Onoue Y, Takao M, Adachi Y, Murakami G, Adachi Y. Itazawa T, et al. Among authors: shimizu m. Pediatr Allergy Immunol. 2024 Dec;35(12):e70017. doi: 10.1111/pai.70017. Pediatr Allergy Immunol. 2024. PMID: 39688180 No abstract available.
Metabolic mechanism of lignin-derived aromatics in white-rot fungi.
Kato H, Miura D, Kato M, Shimizu M. Kato H, et al. Among authors: shimizu m. Appl Microbiol Biotechnol. 2024 Dec 11;108(1):532. doi: 10.1007/s00253-024-13371-4. Appl Microbiol Biotechnol. 2024. PMID: 39661194 Free PMC article. Review.
6,021 results